Kimyrsa 70842-0225-01
Generic: Oritavancin Diphosphate
- Manufacturer
- Melinta Therapeutics, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 23, 2021
- Listing Expires
- December 31, 2026
- Application
- NDA214155
Need to source Kimyrsa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Oritavancin Diphosphate | 1200 mg/40mL |
Drug Class
Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 2C9 Inhibitors [MoA]Cytochrome P450 2D6 Inducers [MoA]
Selected Package
70842-0225-01Selected1 VIAL in 1 CARTON (70842-225-01) / 40 mL in 1 VIAL